piperacillin has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fried, M; Krämer, I; Kühn, M; Rosentreter, J | 1 |
| Alexaki, P; Alivizatos, AS; Athanasiou, AE; Chalkiopoulou, I; Christakis, GB; Zarkadis, IK | 1 |
2 other study(ies) available for piperacillin and Osteogenic Sarcoma
| Article | Year |
|---|---|
Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient.
Topics: Adolescent; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Humans; Male; Methotrexate; Neurotoxicity Syndromes; Osteosarcoma; Piperacillin; Renal Insufficiency | 2021 |
Primary bacteraemia caused by Rhizobium radiobacter in a patient with solid tumours.
Topics: Adult; Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bone Neoplasms; Gram-Negative Bacterial Infections; Humans; Hydroxycorticosteroids; Male; Molecular Sequence Data; Osteosarcoma; Piperacillin; Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S | 2006 |